Home/Filings/4/0001104659-23-065547
4//SEC Filing

Prichard Heather Ledbetter 4

Accession 0001104659-23-065547

CIK 0001818382other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 5:05 PM ET

Size

14.3 KB

Accession

0001104659-23-065547

Insider Transaction Report

Form 4
Period: 2023-05-24
Prichard Heather Ledbetter
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-05-25$1.19/sh+64,990$77,33874,179 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2023-05-2564,9900 total
    Exercise: $1.19From: 2016-11-22Exp: 2023-11-22Common Stock (64,990 underlying)
  • Exercise/Conversion

    Common Stock

    2023-05-24$1.19/sh+13,789$16,40922,978 total
  • Sale

    Common Stock

    2023-05-25$3.83/sh9,613$36,81864,566 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2023-05-2413,78964,990 total
    Exercise: $1.19From: 2016-11-22Exp: 2023-11-22Common Stock (13,789 underlying)
  • Sale

    Common Stock

    2023-05-24$4.14/sh13,789$57,0869,189 total
Footnotes (2)
  • [F1]The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.14 to $4.16. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.82 to $3.89. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Humacyte, Inc.

CIK 0001818382

Entity typeother

Related Parties

1
  • filerCIK 0001877712

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 5:05 PM ET
Size
14.3 KB